ARCHIVES

Tivozanib Does Not Improve OS Compared to Sorafenib

This article is from The Cancer Letter archive.

Vol. 36 No. 2 | February 22, 2013

Download PDF Visit The Full Archive

Related Articles

NCI Begins Latin American Cancer Research Network

April 10, 2009

IND-Exempt Trials May Need Special Review, HCFA Says.

September 29, 2000

Columbia Formally Names As 21st Comprehensive Center

March 9, 1979

Cancer Statistics: Colorectal Cancer Incidence Declines, Annual Report Finds

May 19, 2000

Adamson Elected Chairman Of Children’s Oncology Group

December 11, 2009

Rauscher Mammography Guidelines Would Limit Annual Use To Members Of High Risk Group

August 13, 1976